跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 718 条关于
“HK Innoen”
全部
718
临床试验
358
药物
82
机构
110
资讯
168
9个月前
HK Innoen's K-CAB Receives Brazilian GMP Certification, Advances Global Market Expansion
5个月前
HK inno.N Partners with NEXTGEN to Advance IPF Drug NXC680 into Phase 1 Clinical Trials
去年
HK inno.N Advances Obesity Drug IN-B00009 to Phase 3 Trial in South Korea
2个月前
Analysts Maintain Bullish Stance on InSilico Medicine with Price Targets Up to HK$77.50
2个月前
Analysts Maintain Bullish Stance on HUTCHMED (China) with Buy Ratings and Price Targets Above HK$32
去年
HK inno.N's K-CAB Poised for Indian Market Entry Following Positive Recommendation
11天前
HK inno.N's Kepacab becomes world's first oral finished drug to earn global EPD certification
去年
HKUST and SIIC Launch HK$600 Million Biotechnology Fund to Accelerate Healthcare Innovation
2年前
Transcenta Announces Positive Interim Results, Highlights Osemitamab and Blosozumab Progress
去年
Bixeps Machine Shows Promise in Improving Muscle Strength and Bone Density in Clinical Studies
第 1 页,共 17 页
上一页
下一页